157 related articles for article (PubMed ID: 34081843)
21. Determination of plasma microRNA for early detection of gastric cancer.
Gorur A; Balci Fidanci S; Dogruer Unal N; Ayaz L; Akbayir S; Yildirim Yaroglu H; Dirlik M; Serin MS; Tamer L
Mol Biol Rep; 2013 Mar; 40(3):2091-6. PubMed ID: 23212612
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
Mu YP; Sun WJ; Lu CW; Su XL
Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
[TBL] [Abstract][Full Text] [Related]
23. Gastric juice miR-129 as a potential biomarker for screening gastric cancer.
Yu X; Luo L; Wu Y; Yu X; Liu Y; Yu X; Zhao X; Zhang X; Cui L; Ye G; Le Y; Guo J
Med Oncol; 2013 Mar; 30(1):365. PubMed ID: 23307240
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis value of miR-181, miR-652, and CA72-4 for gastric cancer.
Tian W; Pang X; Luan F
J Clin Lab Anal; 2022 Jun; 36(6):e24411. PubMed ID: 35446997
[TBL] [Abstract][Full Text] [Related]
25. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.
Wang JL; Hu Y; Kong X; Wang ZH; Chen HY; Xu J; Fang JY
PLoS One; 2013; 8(9):e73683. PubMed ID: 24040025
[TBL] [Abstract][Full Text] [Related]
26. Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer.
Li J; Chen Z; Li Q; Liu R; Zheng J; Gu Q; Xiang F; Li X; Zhang M; Kang X; Wu R
PeerJ; 2024; 12():e16660. PubMed ID: 38259671
[TBL] [Abstract][Full Text] [Related]
27. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as potential biomarkers for gastric cancer.
Liu HS; Xiao HS
World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237
[TBL] [Abstract][Full Text] [Related]
29. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
30. Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.
Chu D; Zhao Z; Li Y; Li J; Zheng J; Wang W; Zhao Q; Ji G
PLoS One; 2014; 9(3):e90526. PubMed ID: 24621930
[TBL] [Abstract][Full Text] [Related]
31. Survival prediction of gastric cancer by a seven-microRNA signature.
Li X; Zhang Y; Zhang Y; Ding J; Wu K; Fan D
Gut; 2010 May; 59(5):579-85. PubMed ID: 19951901
[TBL] [Abstract][Full Text] [Related]
32. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
33. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of multi-view data of miRNA-seq to identify miRNA biomarkers for stomach cancer.
Pant N; Rakshit S; Paul S; Saha I
J Biomed Inform; 2019 Sep; 97():103254. PubMed ID: 31352060
[TBL] [Abstract][Full Text] [Related]
35. Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer.
Wu YF; Xu Q; He CY; Li Y; Liu JW; Deng N; Sun LP; Yuan Y
Sci Rep; 2017 Jan; 7():39528. PubMed ID: 28067243
[TBL] [Abstract][Full Text] [Related]
36. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
Su ZX; Zhao J; Rong ZH; Wu YG; Geng WM; Qin CK
Tumour Biol; 2014 Dec; 35(12):12119-25. PubMed ID: 25416437
[TBL] [Abstract][Full Text] [Related]
38. Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer.
Yang H; Fu H; Wang B; Zhang X; Mao J; Li X; Wang M; Sun Z; Qian H; Xu W
Mol Carcinog; 2018 Sep; 57(9):1223-1236. PubMed ID: 29749061
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-21: Mechanisms of Oncogenesis and its Application in Diagnosis and Prognosis of Gastric Cancer.
Karimi Kurdistani Z; Saberi S; Tsai KW; Mohammadi M
Arch Iran Med; 2015 Aug; 18(8):524-36. PubMed ID: 26265521
[TBL] [Abstract][Full Text] [Related]
40. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review.
Li H; Wu Q; Li T; Liu C; Xue L; Ding J; Shi Y; Fan D
Oncotarget; 2017 Jul; 8(28):45060-45071. PubMed ID: 28178677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
